Correspondence 0001140361-22-042358 from Figure Acquisition Corp. I (CIK 0001839550)

Figure Acquisition Corp. I (CIK 0001839550)
Date: Nov. 18, 2022 · CIK: 0001839550 · Accession: 0001140361-22-042358

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-40081

Referenced dates: November 17, 2022

Date

November 18, 2022

Author

/s/ Derek Dostal

Form

CORRESP

Company

Figure Acquisition Corp. I (CIK 0001839550)

Letter

Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E., Washington, D.C. 20549 Attention : Jeffrey Gabor & Benjamin Holt

Dear Mr. Gabor and Mr. Holt:

On behalf of our client, Figure Acquisition Corp. I (the “Company”), this letter sets forth the Company’s response to the comments provided by the Staff (“the Staff”) of the Division of Corporation Finance of the U.S. Securities and Exchange Commission in your letter dated November 17, 2022, relating to the Company’s preliminary proxy statement on Schedule 14A (the “Preliminary Proxy Statement”), filed on November 3, 2022.

The Company has updated the Preliminary Proxy Statement and is filing a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”) together with this response letter, which contains certain additional updates and revisions. Set forth below are the Company’s responses to the Staff’s comments. For the Staff’s convenience, the Staff’s comment is restated in italics prior to the Company’s response.

Preliminary Proxy Statement on Schedule 14A filed November 3, 2022

General

With a view toward disclosure, please tell us whether your sponsor is, is controlled by, or has substantial ties with a non-U.S. person. If so, also include risk factor disclosure that addresses how this fact could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination with a U.S. target company should the transaction be subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that as a result, the pool of potential targets with which you could complete an initial business combination may be limited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants, which would expire worthless.

In response to the Staff’s comment, the Company respectfully advises the Staff that the Company’s sponsor, Fintech Acquisition LLC, is not controlled by, and does not have substantial ties with a non-U.S. person, and the Company does not believe that there are any risks to disclose to investors that a proposed business combination with the Company would be subject to regulatory review by a U.S. government entity, such as CFIUS, or would ultimately be prohibited.

U.S. Securities and Exchange

Commission

* * *

Please do not hesitate to contact the undersigned if you have any questions regarding the foregoing or if we may provide any additional information.

Very truly yours,
/s/ Derek Dostal

Show Raw Text

CORRESP
1
filename1.htm

Derek Dostal

+1 212 450 4322

derek.dostal@davispolk.com

Davis Polk & Wardwell llp

450 Lexington Avenue

New York, NY 10017

davispolk.com

November 18, 2022

Re:

Figure Acquisition Corp. I

Preliminary Proxy Statement on Schedule 14A

Filed November 3, 2022

File No. 001-40081

CONFIDENTIAL

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Real Estate & Construction

100 F Street, N.E., Washington, D.C. 20549

Attention :

Jeffrey Gabor & Benjamin Holt

Dear Mr. Gabor and Mr. Holt:

On behalf of our client, Figure Acquisition Corp. I (the “Company”), this letter sets forth the Company’s response to the comments provided by the Staff (“the Staff”) of the
Division of Corporation Finance of the U.S. Securities and Exchange Commission in your letter dated November 17, 2022, relating to the Company’s preliminary proxy statement on Schedule 14A (the “Preliminary Proxy Statement”), filed on
November 3, 2022.

The Company has updated the Preliminary Proxy Statement and is filing a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”) together with this response
letter, which contains certain additional updates and revisions. Set forth below are the Company’s responses to the Staff’s comments. For the Staff’s convenience, the Staff’s comment is restated in italics prior to the Company’s response.

Preliminary Proxy Statement on Schedule 14A filed November 3, 2022

General

With a view toward disclosure, please tell us whether your sponsor is, is controlled by, or has substantial ties with a non-U.S. person. If so,
also include risk factor disclosure that addresses how this fact could impact your ability to complete your initial business combination. For instance, discuss the risk to investors that you may not be able to complete an initial
business combination with a U.S. target company should the transaction be subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Disclose that
as a result, the pool of potential targets with which you could complete an initial business combination may be limited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the
transaction could prevent you from completing an initial business combination and require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants, which would expire worthless.

In response to the Staff’s comment, the Company respectfully advises the Staff that the Company’s sponsor, Fintech Acquisition LLC, is not controlled by, and does not have substantial ties
with a non-U.S. person, and the Company does not believe that there are any risks to disclose to investors that a proposed business combination with the Company would be subject to regulatory review by a U.S. government entity, such as CFIUS, or
would ultimately be prohibited.